We assumed worse outcomes in women with PCOS than in controls even after progesterone administration due to the previous endometrial proliferation linked to oestrogen action and the effects of insulin and androgen on the endometrium of such patients [4,6,9]. This evidence concerns the gene INS and polycystic ovary syndrome.